- Home
- RVTY vs BMRN Comparison
RVTY vs BMRN Comparison
Compare RVTY & BMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RVTY | BMRN |
|---|---|---|
| Founded | 1937 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Laboratory Analytical Instruments | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.9B | 10.5B |
| IPO Year | N/A | 1999 |
Fundamental Metrics
Financial Performance| Metric | RVTY | BMRN |
|---|---|---|
| Price | $100.79 | $53.40 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 13 | 19 |
| Target Price | ★ $112.92 | $88.42 |
| AVG Volume (30 Days) | 1.7M | ★ 3.0M |
| Earning Date | 10-27-2025 | 10-27-2025 |
| Dividend Yield | ★ 0.28% | N/A |
| EPS Growth | N/A | ★ 59.53 |
| EPS | 1.99 | ★ 2.68 |
| Revenue | $2,813,367,000.00 | ★ $3,094,001,000.00 |
| Revenue This Year | $5.33 | $13.39 |
| Revenue Next Year | $3.07 | $7.57 |
| P/E Ratio | $51.70 | ★ $19.92 |
| Revenue Growth | 3.37 | ★ 12.39 |
| 52 Week Low | $81.36 | $50.76 |
| 52 Week High | $128.29 | $73.51 |
Technical Indicators
Market Signals| Indicator | RVTY | BMRN |
|---|---|---|
| Relative Strength Index (RSI) | 57.32 | 46.19 |
| Support Level | $99.35 | $53.03 |
| Resistance Level | $104.84 | $54.66 |
| Average True Range (ATR) | 3.06 | 1.45 |
| MACD | 0.33 | -0.11 |
| Stochastic Oscillator | 66.03 | 31.61 |
Price Performance
Historical ComparisonAbout RVTY Revvity Inc.
Revvity provides instruments, tests, services, and software solutions to the pharmaceutical, biomedical, chemical, environmental, and general industrial markets. The company operates in two segments. First, its diagnostics segment includes immunodiagnostics, reproductive health, and applied genomics. Second, its discovery and analytical solutions is composed of life science, industrial, environmental, and food applications. Revvity offers products and services ranging from genetic screening and environmental analytical tools to informatics and enterprise software.
About BMRN BioMarin Pharmaceutical Inc.
BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments designed to address complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria, hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development across skeletal conditions and enzyme therapies.